vepdegestrant
vepdegestrant is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including VEPPANU. Available dosage forms: tablet, tablet, film coated.
Drug Details
- Generic Name
- vepdegestrant
- Brand Names
- VEPPANU
- Application Number
- NDA219835
- Sponsor
- Arvinas Operations, Inc.
- NDC Codes
- 4
- Dosage Forms
- TABLET, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- VEPDEGESTRANT
Indications and Usage
1 INDICATIONS AND USAGE VEPPANU is indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1) -mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy. VEPPANU is a heterobifunctional protein degrader indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 ( ESR1) -mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy. ( 1 )